These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 30542181)
1. Designer viruses could be the secret to cheaper and better gene therapy. Savage N Nature; 2018 Dec; 564(7735):S18-S19. PubMed ID: 30542181 [No Abstract] [Full Text] [Related]
12. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice. Scallan CD; Jiang H; Liu T; Patarroyo-White S; Sommer JM; Zhou S; Couto LB; Pierce GF Blood; 2006 Mar; 107(5):1810-7. PubMed ID: 16249376 [TBL] [Abstract][Full Text] [Related]
13. Immune responses to AAV capsid: are mice not humans after all? Herzog RW Mol Ther; 2007 Apr; 15(4):649-50. PubMed ID: 17372595 [No Abstract] [Full Text] [Related]
14. Structure of adeno-associated virus serotype 8, a gene therapy vector. Nam HJ; Lane MD; Padron E; Gurda B; McKenna R; Kohlbrenner E; Aslanidi G; Byrne B; Muzyczka N; Zolotukhin S; Agbandje-McKenna M J Virol; 2007 Nov; 81(22):12260-71. PubMed ID: 17728238 [TBL] [Abstract][Full Text] [Related]
15. Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies. Li Y; Li J; Liu Y; Shi Z; Liu H; Wei Y; Yang L Gene Ther; 2019 Jun; 26(6):264-276. PubMed ID: 31110296 [TBL] [Abstract][Full Text] [Related]
16. Hemophilia Gene Therapy: Caught Between a Cure and an Immune Response. Herzog RW Mol Ther; 2015 Sep; 23(9):1411-2. PubMed ID: 26321180 [No Abstract] [Full Text] [Related]
17. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial. Monahan PE; Sun J; Gui T; Hu G; Hannah WB; Wichlan DG; Wu Z; Grieger JC; Li C; Suwanmanee T; Stafford DW; Booth CJ; Samulski JJ; Kafri T; McPhee SW; Samulski RJ Hum Gene Ther; 2015 Feb; 26(2):69-81. PubMed ID: 25419787 [TBL] [Abstract][Full Text] [Related]
18. Using a barcoded AAV capsid library to select for clinically relevant gene therapy vectors. Pekrun K; De Alencastro G; Luo QJ; Liu J; Kim Y; Nygaard S; Galivo F; Zhang F; Song R; Tiffany MR; Xu J; Hebrok M; Grompe M; Kay MA JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723052 [TBL] [Abstract][Full Text] [Related]
19. [Characterization and application of adeno-associated virus serotype 8 as a gene transfer vector]. Wang G; Wu XB Bing Du Xue Bao; 2011 Jan; 27(1):91-5. PubMed ID: 21462514 [No Abstract] [Full Text] [Related]
20. AAV-Mediated Gene Delivery to the Liver: Overview of Current Technologies and Methods. Palaschak B; Herzog RW; Markusic DM Methods Mol Biol; 2019; 1950():333-360. PubMed ID: 30783984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]